Domov › Dysfunkcia ľavej komory › New York
Klinické štúdie Dysfunkcia ľavej komory v štáte New York
4 štúdií pre Dysfunkcia ľavej komory hľadá účastníkov v zariadeniach v štáte New York.
Mestá v štáte New York
Oficiálny text štúdie (anglicky)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Columbia University Medical Center-Pediatric Cardiology ( Site 0016), New York
- The Children's Hospital at Montefiore ( Site 0030), The Bronx
Prebieha náborFáza 2/3
29 Days – 17 Years · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
- The Children's Hospital at Montefiore - Cardiology, The Bronx
Prebieha náborFáza 3
Do veku 18 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
- The Children's Hospital at Montefiore - Cardiology, The Bronx
Prebieha náborFáza 3
6 Months – 17 Years · Všetky pohlavia · Aktualizované 15. 6. 2026 · NCT07188805AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Mount Sinai Hospital, New York
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 6. 2026 · NCT06699056Z ClinicalTrials.gov, dáta načítané 4. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.